NCT05322889View on ClinicalTrials.gov

Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel)

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 9, 2020

Primary Completion Date

October 4, 2022

Study Completion Date

June 30, 2023

Conditions
Neuropathic PainChemotherapy Effect
Interventions
DRUG

Telmisartan tablets

12 weeks treatment

Trial Locations (1)

60590

Department of Haematology/Medical Onkology, University Hospital, Goethe-University Frankfurt, Frankfurt

All Listed Sponsors
collaborator

Johann Wolfgang Goethe University Hospital

OTHER

lead

Dr. Frank Behrens

OTHER

NCT05322889 - Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel) | Biotech Hunter | Biotech Hunter